Name Development Level Target Family
Name Description
bevacizumab An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF RECEPTORS and helps prevent the proliferation of blood vessels.
TCRDv5.4.0
DrugCentral Indication
bevacizumab